ATE404205T1 - Neue zusammenstellung von agomelatin und einem noradrenalin-wideraufnahme-hemmer und pharmazeutische zusammensetzungen, die sie enthalten - Google Patents

Neue zusammenstellung von agomelatin und einem noradrenalin-wideraufnahme-hemmer und pharmazeutische zusammensetzungen, die sie enthalten

Info

Publication number
ATE404205T1
ATE404205T1 AT06291421T AT06291421T ATE404205T1 AT E404205 T1 ATE404205 T1 AT E404205T1 AT 06291421 T AT06291421 T AT 06291421T AT 06291421 T AT06291421 T AT 06291421T AT E404205 T1 ATE404205 T1 AT E404205T1
Authority
AT
Austria
Prior art keywords
rupup
agomelatin
noradrenaline
inhibitor
pharmaceutical compositions
Prior art date
Application number
AT06291421T
Other languages
English (en)
Inventor
Elisabeth Mocaer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE404205T1 publication Critical patent/ATE404205T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06291421T 2005-09-09 2006-09-08 Neue zusammenstellung von agomelatin und einem noradrenalin-wideraufnahme-hemmer und pharmazeutische zusammensetzungen, die sie enthalten ATE404205T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509206A FR2890564B1 (fr) 2005-09-09 2005-09-09 Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
ATE404205T1 true ATE404205T1 (de) 2008-08-15

Family

ID=36190808

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06291421T ATE404205T1 (de) 2005-09-09 2006-09-08 Neue zusammenstellung von agomelatin und einem noradrenalin-wideraufnahme-hemmer und pharmazeutische zusammensetzungen, die sie enthalten

Country Status (40)

Country Link
US (1) US7622505B2 (de)
EP (1) EP1769798B1 (de)
JP (2) JP5395998B2 (de)
KR (1) KR100863384B1 (de)
CN (1) CN1927205A (de)
AP (1) AP2615A (de)
AR (1) AR056056A1 (de)
AT (1) ATE404205T1 (de)
AU (1) AU2006209368B2 (de)
BR (1) BRPI0603759A (de)
CA (1) CA2558782C (de)
CY (1) CY1108319T1 (de)
DE (1) DE602006002210D1 (de)
DK (1) DK1769798T3 (de)
EA (1) EA011650B1 (de)
ES (1) ES2313590T3 (de)
FR (1) FR2890564B1 (de)
GE (1) GEP20094742B (de)
GT (1) GT200600408A (de)
HR (1) HRP20080535T3 (de)
JO (1) JO2521B1 (de)
MA (1) MA28505B1 (de)
ME (2) ME02758B (de)
MX (1) MXPA06010157A (de)
MY (1) MY142260A (de)
NO (1) NO338029B1 (de)
NZ (1) NZ549725A (de)
PE (1) PE20070429A1 (de)
PL (1) PL1769798T3 (de)
PT (1) PT1769798E (de)
PY (1) PY0626552A (de)
RS (1) RS50631B (de)
SA (1) SA06270308B1 (de)
SG (1) SG131030A1 (de)
SI (1) SI1769798T1 (de)
TW (1) TWI324513B (de)
UA (1) UA83542C2 (de)
UY (1) UY29778A1 (de)
WO (1) WO2007028904A1 (de)
ZA (1) ZA200607562B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608737B2 (en) 2007-05-01 2009-10-27 Concert Pharmaceuticasl Inc. Naphthyl(ethyl)acetamides
US20080280991A1 (en) * 2007-05-08 2008-11-13 Auspex Pharmaceuticals, Inc. Substituted naphthalenes
CN102342924A (zh) * 2010-08-05 2012-02-08 北京本草天源药物研究院 一种含有阿戈美拉汀的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
WO1999020279A1 (en) * 1997-10-17 1999-04-29 Eli Lilly And Company Potentiation of pharmaceuticals
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
EP1478400A1 (de) * 2002-02-26 2004-11-24 Ortho-McNeil Pharmaceutical, Inc. Therapie zur behandlung von migräne bestehend aus antikonvulsiven derivaten und antimigränemitteln
JP2004292445A (ja) * 2003-03-11 2004-10-21 Katsunori Nonogaki 糖尿病治療薬
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
AU2004271796A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Combination comprising an alpha-2-delta ligand and an SSRI and/or SNRI for treatment of depression and anxiety disorders

Also Published As

Publication number Publication date
AP2008004378A0 (en) 2008-04-30
NO20064048L (no) 2007-03-12
FR2890564A1 (fr) 2007-03-16
GT200600408A (es) 2007-05-21
SG131030A1 (en) 2007-04-26
AR056056A1 (es) 2007-09-12
EP1769798A1 (de) 2007-04-04
MXPA06010157A (es) 2007-03-08
CN1927205A (zh) 2007-03-14
RS50631B (sr) 2010-06-30
AU2006209368A1 (en) 2007-03-29
ME02758B (de) 2010-06-30
MA28505B1 (fr) 2007-04-03
DK1769798T3 (da) 2008-11-24
JP2011088919A (ja) 2011-05-06
PY0626552A (es) 2011-01-03
WO2007028904A1 (fr) 2007-03-15
ZA200607562B (en) 2008-05-28
KR100863384B1 (ko) 2008-10-13
UA83542C2 (uk) 2008-07-25
JO2521B1 (en) 2010-03-17
AP2615A (en) 2013-03-14
TW200744570A (en) 2007-12-16
CA2558782A1 (fr) 2007-03-09
CA2558782C (fr) 2012-05-15
FR2890564B1 (fr) 2007-10-19
JP5395998B2 (ja) 2014-01-22
EP1769798B1 (de) 2008-08-13
BRPI0603759A (pt) 2007-05-15
UY29778A1 (es) 2006-10-31
NO338029B1 (no) 2016-07-25
SI1769798T1 (sl) 2008-12-31
AU2006209368B2 (en) 2012-07-19
EA200601410A1 (ru) 2007-04-27
US20070060654A1 (en) 2007-03-15
JP2007077147A (ja) 2007-03-29
PE20070429A1 (es) 2007-06-02
TWI324513B (en) 2010-05-11
HRP20080535T3 (en) 2008-12-31
EA011650B1 (ru) 2009-04-28
PT1769798E (pt) 2008-09-18
ES2313590T3 (es) 2009-03-01
SA06270308B1 (ar) 2011-10-08
GEP20094742B (en) 2009-07-27
PL1769798T3 (pl) 2008-12-31
NZ549725A (en) 2008-03-28
ME02767B (de) 2010-06-30
MY142260A (en) 2010-11-15
KR20070029606A (ko) 2007-03-14
US7622505B2 (en) 2009-11-24
DE602006002210D1 (de) 2008-09-25
CY1108319T1 (el) 2014-02-12

Similar Documents

Publication Publication Date Title
ATE466855T1 (de) Zusammensetzungen verwendbar für die hemmung von rock und anderen kinasen
EP1962827A4 (de) Pharmazeutische zusammensetzungen von kombinationen von dipeptidyl-peptidase-4-hemmern mit metformin
DE60306565D1 (de) Zusammensetzungen gegen Krebs zur topischen Anwendung
DK2063868T3 (da) Farmaceutiske sammensætninger indeholdende rosuvastatin-calcium
IL187997A0 (en) Indane derivatives and pharmaceutical compositions containing the same
IL191141A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL186665A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
NO20092104L (no) Nye 1,2-dihydroquinolinderivater, farmasøytisk sammensetning inneholdende slike, samt anvendelse derav
DK1909764T3 (da) Farmaceutisk sammensætninger omfattende levetiracetam og fremgangsmåde til deres fremstilling
IL189782A (en) The history of sulfonylpyrol and its medicinal products and their use
IL208497A0 (en) Pharmaceutical compositions containing erythropoietin and derivatives thereof
IL187534A0 (en) Thiazole derivatives, use thereof and pharmaceutical compositions containing them
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CL2007003841A1 (es) Compuestos derivados de 4(5h-1 lambda-tiazol-2-il)piperidina; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar diabetes.
ATE409470T1 (de) Pharmazeutische zusammensetzungen mit malonamid- derivaten zur verringerung der talg-produktion
PT1858481T (pt) Composições oftalmológicas e sua utilização
ATE404205T1 (de) Neue zusammenstellung von agomelatin und einem noradrenalin-wideraufnahme-hemmer und pharmazeutische zusammensetzungen, die sie enthalten
IL191992A0 (en) Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
EP1937255A4 (de) Pharmazeutische zusammensetzung
BRPI0611748A2 (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
DE602006019961D1 (de) Kristalline base von escitalopram und orodispergierbare tabletten, die escitaloprambase enthalten
EP1723970A4 (de) Medizinische zusammensetzung mit cxcr3-hemmer
EP2121596A4 (de) Atorvastatin-strontiumsalz und pharmazeutische zusammensetzung, die dieses enthält
DE502004009045D1 (de) Injizierbare darreichungsform von flupirtin
DE602006008797D1 (de) Hibitoren, und pharmazeutische zusammensetzungen, die sie enthalten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1769798

Country of ref document: EP